Will Cannabis Genetics Be Banned?

A redefinition of hemp under federal law, scheduled to take place Nov. 12, signals the loss of Farm Bill protections for many hemp-derived THC items across the country: mild beverages as well as THCA flower and delta-8 THC gummies, vapes and additional products available at gas stops and smoke shops.

But the hemp prohibition also creates a significant complication for the legal cannabis sector. Seeds from cannabis cultivars that produce flower with more than 0.3% THC are no longer legal to transport out of state.

Although seed buying will probably continue in legal states, the changes threaten to close some seed banks and genetics companies, observers say, while creating supply-chain issues for cannabis growers and retailers.

"If this wording goes forward, we will need pop-up shops to sell seeds in each state where it's legal," Campanella said. "Which is why we're also offering clones and tissue cultivation, because that's not covered in the bill."

When are cannabis genetics and clones illegal to ship between state lines?

The updated regulations categorize seeds based on the THC capacity of the parent plant. Genetic material such as seeds and https://nativesusa.com/ (nativesusa.com) clones are rendered illegal if the end product crosses the threshold.

For now, seeds are currently shipping under the 2018 Farm Bill's status quo. But the clock is ticking for enterprises like Brothers Grimm and for cannabis growers who worry about supply chain disruptions if out-of-state access to genetics is banned.

Most of the cannabis sector remains largely unaware of the impending shutdown of the interstate genetics marketplace, said Ryan Power, cofounder of Sebastopol, California-based breeder Atlas Seed.

Without federal intervention in the form of a carve-out for seeds or an overall moratorium, numerous seed providers will simply be shuttered come November, he added.

"We are operating legally currently, but if that changes, it will upend the legal licensed sector in each state," said Power, whose customers includes seed banks as well as licensed business cultivators.

"Consumers are going to lose choice, and it will be a significant shutdown for many people."

What are cannabis seed banks doing to remain legal after the government hemp ban?

Sagui Silber has previously recalibrated Silberhaze Genetics, his Ohio genetics company, because of state Senate Bill 56, which strengthened cannabis supervision in that state while also restricting hemp-derived THC products to licensed cannabis retailers.

Previously a seed bank, Silberhaze is currently focused on the branding, preservation and IP safeguarding of elite plant genetics.

That's because seed businesses hoping to remain compliant in this updated environment must have solid documentation, he said.

"You have to prove where this material comes from, so it's extremely important to have documentation, even to the point where you have cultivator names," Silber said.

"Smaller businesses will have to operate with improved records and a better chain of possession," he added. "We want that documentation too, because we don't want to be dealing with questionable sources."

To avoid seizures and other legal fallout, seed entrepreneurs must "get their ducks in a row" before the new regulations take place, Silber said.

"Review all your stuff immediately, and classify what you can," Silber said. "Take stock, document your lineage, preserve breeder records, and arrange any cannabinoid or terpene data you currently have. If regulations shift, you'll be in a far better position to comprehend what may be impacted and make informed decisions."

Does government marijuana rescheduling affect cannabis genetics?

Silber believes U.S. Drug Enforcement Administration registration may be necessary for businesses engaged in research.

But for now, seed companies can't enroll with the DEA like state-licensed medical cannabis operators can. Such an option is unavailable to seed suppliers, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward's cannabis law group in Cleveland.

"Genetics activity may be occurring inside larger state-licensed therapeutic marijuana businesses, as some states permit dispensaries or registered therapeutic operators to offer seeds, clones or personal growing materials," he said.

"But that is distinct from the DEA creating a freestanding seed supplier registration category."

Some genetics operators are already changing business practices to comply with the updated law. According to Ickes, they must address questions including:

• Which of our lines produce plants over 0.3% total THC?
• Which seeds remain as hemp after Nov. 12, 2026, and which don't?
• What does our inventory look like once we sort it against the viable-seed exclusion?

Ickes also recognizes confusion from clients who believed federal rescheduling of medical marijuana would clarify their story with banking institutions. However, the latest regulatory wording has shifted those conversations beyond the fundamentals of classification, he said.

"Banks ask whether this particular revenue source is lawful, whether it ties to state-licensed operations, or whether there's cross-state risk," said Ickes.

"After November, a seed bank selling drug-type genetics can't answer the first question with the hemp definition. It has to refer to a lawful state cannabis channel instead. Seed banks dealing in authentic industrial-hemp seed maintain the cleaner story."

What's the future of cannabis genetics?

Campanella is a member of a emerging coalition of fellow breeders, growers and researchers that's arguing seeds are more appropriately defined as farm inputs than controlled substances. To that end, seeds should be overseen by the U.S. Department of Agriculture, leaving the DEA to focus its enforcement work elsewhere.

"How do you regulate something based on what it might become one day?" said Campanella. "Our choice is to have that language removed, or have seeds regulated by the USDA as a hemp product."

But in the meantime, Campanella is restructuring Brothers Grimm to function outside the reach of changing federal oversight. The company plans to keep its Colorado seed facility while positioning its Oklahoma tissue culture facility as a hedge against government prohibition of cannabis seeds.

As she explained: "If things evolve in a way where we can't concentrate on interstate transport, we'll have additional resources to satisfy people's requirements without putting ourselves in trouble."